Company-wide revenue
Reported revenue in 2021 ¥33.6B Reported revenue in 2025 ¥54.98B
- growth amount
- +¥21.39B
- growth annualized
- +13.1%
- growth total
- +63.7%
Japanese company profile · 3353
Medical Ikkou Group Co.,Ltd.
In its FY2025 public filing, Medical Ikkou Group Co.,Ltd. reports Pharmacy, Healthcare, Pharmaceutical wholesale, Real Estate. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 株式会社メディカル一光グループ
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
Medical Ikkou Group Co.,Ltd.'s largest reported business by revenue in FY2025 was Pharmacy.
The business with the highest reported segment profit in FY2025 was Pharmacy.
FY2025 · fiscal year ended February 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Pharmacy | ¥26.29B ↗ | 47.8% | ¥1.37B ↗ |
| Pharmaceutical wholesale | ¥20.64B ↗ | 37.5% | ¥287.22M ↗ |
| Healthcare | ¥8.99B ↗ | 16.4% | ¥111.53M ↗ |
| Real Estate | ¥265.28M ↗ | 0.5% | ¥144.61M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended February 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Pharmacy
- 調剤薬局事業
- Healthcare
- ヘルスケア事業
- Pharmaceutical wholesale
- 医薬品卸事業
- Real Estate
- 不動産事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Pharmacy
- 調剤薬局事業
- Healthcare
- ヘルスケア事業
- Pharmaceutical wholesale
- 医薬品卸事業
- Real Estate
- 不動産事業
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Pharmacy | ¥22.73B | ¥23.09B | ¥23.54B | ¥24.71B | ¥26.29B |
| Healthcare | ¥7.81B | ¥7.67B | ¥7.75B | ¥8.12B | ¥8.99B |
| Pharmaceutical wholesale | ¥3.89B | ¥3.94B | ¥9.31B | ¥16.2B | ¥20.64B |
| Real Estate | ¥233.2M | ¥189.05M | ¥185.64M | ¥208.4M | ¥265.28M |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Pharmaceutical wholesale
Reported revenue in 2021 ¥3.89B Reported revenue in 2025 ¥20.64B
- growth amount
- +¥16.75B
- growth annualized
- +51.8%
- growth total
- +430.4%
View original filing
Pharmacy
Reported revenue in 2021 ¥22.73B Reported revenue in 2025 ¥26.29B
- growth amount
- +¥3.56B
- growth annualized
- +3.7%
- growth total
- +15.7%
View original filing
Healthcare
Reported revenue in 2022 ¥7.67B Reported revenue in 2025 ¥8.99B
- growth amount
- +¥1.32B
- growth annualized
- +5.4%
- growth total
- +17.2%
View original filing
Healthcare
Reported profit margin in 2022 -0.4%
Reported profit margin in 2025 +1.2%
- growth margin points
- +1.6
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended February 2026
The source document may be in Japanese.
Filing ID: S100Y4Y9
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.